A variety of factors can result in obsolete laboratory equipment and R&D devices. Completing a project, upgrading equipment, closing a lab or downsizing, for example, typically create surplus pharmaceutical assets no longer required in the same capacity—or at all.
Between budget restrictions and the need to adhere to fiscal and environmentally-sound business practices, organizations can’t afford to allow surplus assets to lie idle or dispose of them in traditional ways. Surplus requires an innovative and sustainable process that supports strategic business goals.
Comments are closed.